Sudden cardiac death in young competitive athletes due to genetic cardiac abnormalities
1Division of Cardiology, Roosevelt Hospital Center Columbia University, College of Physicians & Surgeons New York City, NY, USA
2Division of Cardiology and Pre-Exercise Heart Screening Program St. Luke’s - Roosevelt Hospital Center Columbia University, College of Physicians & Surgeons New York City, NY, USA
Anatol J Cardiol 2009; (9): 17-23 PubMed ID: 20089483
Full Text PDF

Abstract

Sudden cardiac death (SCD) in young athletes is generally caused by inherited cardiac disorders. While these events are relatively few compared to other cardiac deaths, they are tragic in that death occurs in a young, otherwise healthy person. The genetic abnormalities most associated with SCD are hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, long QT syndrome, Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia. As a result of growing awareness that these deaths can be prevented, guidelines have been issued in both Europe and the United States to help screen and determine qualification for young persons who want to participate in competitive athletics. There remains debate on the how extensive screening should be, in particular over the use of the 12-lead electrocardiogram (ECG), with European guidelines mandating ECG and United States guidelines not recommending routine use of the ECG. (Anadolu Kardiyol Derg 2009; 9: Suppl 2; 17-23)